Phase III Study on HMPL-523 for Treatment of ITP

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

272

Participants

Timeline

Start Date

October 27, 2021

Primary Completion Date

March 31, 2025

Study Completion Date

May 30, 2025

Conditions
Primary Immune Thrombocytopenia (ITP)
Interventions
DRUG

HMPL-523

HMPL-523 will be oral administrated once daily for 24 weeks

DRUG

Placebo

HMPL-523 matching placebo will be oral administrated once daily for 24 weeks .

Trial Locations (37)

Unknown

The First Affiliated Hospital of Anhui Medical University, Hefei

The First Affiliated hospital of USTC, Hefei

Beijing Chaoyang Hospital of Capital Medical University, Beijing

Peking Union Medical College Hospital, Beijing

People's Hospital of Peking University, Beijing

Fujian Medical University Union Hospital, Fuzhou

Lanzhou University Second Hospital, Lanzhou

Guangdong General Hospital, Guangzhou

Southern Hospital of Southern Medical University, Guangzhou

The Second People's Hospital Of Shenzhen, Shenzhen

The First Affiliated Hospital Of GuangXi Medical University, Nanning

The First Hospital of Hebei Medical University, Shijiazhuang

Affiliated Hospital of North China University of Technology, Tangshan

First Affiliated Hospital of Zhengzhou University, Zhengzhou

Henan Cancer Hospital, Zhengzhou

Union Hospital affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan

Xiangyang Central Hospital, Xiangyang

The Third Xiangya Hospital of Central South University, Changsha

Xiangya Hospital Central South University, Changsha

The First Affiliated Hospital of Soochow University, Suzhou

The First Affiliated Hospital of Nanchang University, Nanchang

Shengjing Hospital of China Medical University, Shenyang

The Affiliated Huai'an No.1 People's Hospital of Nanjing Medical University, Huai'an

Qinghai province people's hospital, Xining

Jinan Central Hospital Affilated to Sandong University, Jinan

LiaoCheng People's Hospital, Liaocheng

The Affiliated Hospital of Qingdao University, Qingdao

Jinshan Hospital Affiliated To Fudan University, Shanghai

Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai

Heping Hospital Affiliated to Changzhi Medical College, Changzhi

The second hospital of Shanxi Medical University, Taiyuan

Shanxi Provincial People's Hospital, Xi’an

West China Hospital,Sichuan University, Chengdu

The First Affilicated Hospital of Xinjiang Medical University, Ürümqi

Blood Institute of the Chinese Academy of Medical Sciences, Tianjin

The second Affiliated Hospital of Kunming Medical University, Kunming

Zhejiang Provincial Hospital of Chinese Medicine, Hangzhou

All Listed Sponsors
lead

Hutchison Medipharma Limited

INDUSTRY